Office for Life Sciences Bulletin - 30th October 2020

Page 1

Office for Life Sciences Bulletin – 30 October 2020

OLS Introduction The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS). This bulletin aims to keep the life sciences sector up to date on the latest guidance as we approach the end of the Transition Period and during the Coronavirus (COVID-19) outbreak, providing you with information from Government to help your members and networks prepare. If you would like to be added to the distribution list, please email Sonia.Davies@officeforlifesciences.gov.uk

News NEW - The UK–Japan Comprehensive Economic Partnership Agreement (CEPA) is the first major trade deal that the UK has struck as an independent trading nation. This deal could boost trade between the UK and Japan by over £15 billion and drive economic growth in the long run. A summary document has been published, giving an overview of the benefits for UK businesses, by sector. NEW - Novel COVID-19 Antibody therapy candidates have been identified by the UK BIA Antibody Task Force A leading UK biotech consortium developing antibodies for treating COVID-19 has reached a major milestone – the identification of differentiated antibody combinations that will be taken forward for further development as an antibody “cocktail”. The consortium – the UK BIA Antibody Taskforce of which the National Institute for Biological Standards and Control is a member – developed an accelerated and rigorous multifaceted approach to create a pool of over 600 novel candidates and identified a set of antibodies with the greatest potential. Please see further information on the BioIndustry Association’s website.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.